cf) The inclusion criteria for onychomycosis in the test dataset were a positive KOH test or fungal culture result, or the successful treatment with antifungal drugs. The inclusion criteria for nail dystrophy were a negative KOH test or culture result, unresponsiveness to antifungal medication, or reponsiveness to a triamcinolone intralesional injection.

se/sp
Aruba 100% 1 0 -/100%
Cambodia 100% 3 0 -/100%
Armenia 100% 2 0 -/100%
Macedonia 83% 19 4 93%/67%
Burundi 80% 8 2 0%/100%
Zambia 75% 6 2 50%/83%
Qatar 75% 3 1 0%/100%
Palestinian Territory 75% 15 5 89%/64%
Luxembourg 71% 22 9 0%/100%
Somalia 70% 7 3 83%/50%
Thailand 70% 63 27 69%/71%
Georgia 70% 73 32 63%/76%
Lithuania 69% 9 4 33%/80%
Saudi Arabia 67% 208 102 69%/65%
Guinea-Bissau 67% 2 1 0%/100%
Seychelles 67% 2 1 0%/100%
Cyprus 66% 23 12 57%/71%
Korea 64% 6472 3600 81%/50%
Trinidad and Tobago 64% 7 4 33%/75%
Sri Lanka 62% 13 8 50%/67%
Finland 61% 19 12 20%/100%
Slovenia 60% 49 32 56%/65%
Uganda 60% 29 19 44%/78%
Uzbekistan 60% 59 39 58%/62%
Samoa 60% 6 4 100%/33%
Spain 60% 469 318 38%/77%
Honduras 59% 19 13 53%/65%
Turkey 59% 232 159 63%/57%
Puerto Rico 59% 16 11 30%/76%
Greece 59% 128 89 42%/71%
Ecuador 58% 49 35 57%/60%
El Salvador 58% 14 10 58%/58%
Peru 58% 51 37 64%/51%
Belarus 57% 125 93 16%/89%
Panama 57% 8 6 17%/88%
Jordan 57% 12 9 47%/83%
Ukraine 57% 87 66 45%/67%
Hungary 57% 398 306 71%/45%
Hong Kong 57% 13 10 70%/46%
Moldova 57% 13 10 11%/86%
Tanzania 56% 9 7 20%/73%
Slovakia 56% 36 28 42%/65%
Pakistan 56% 83 65 32%/76%
USA 56% 857 674 50%/61%
Tajikistan 56% 33 26 29%/74%
China 56% 58 46 51%/61%
United Kingdom 56% 351 279 39%/69%
Germany 56% 1010 804 32%/75%
Denmark 56% 25 20 55%/56%
Bangladesh 56% 75 60 73%/41%
Sweden 55% 71 57 45%/63%
Taiwan 55% 46 37 29%/69%
Mexico 55% 169 136 52%/58%
Kazakhstan 55% 41 33 38%/70%
Turkmenistan 55% 21 17 43%/63%
Morocco 55% 70 57 28%/79%
Netherlands 55% 113 93 58%/51%
Switzerland 55% 143 119 50%/59%
Niger 55% 6 5 50%/57%
Ethiopia 54% 43 36 35%/69%
Canada 54% 221 186 37%/69%
Austria 54% 105 90 41%/64%
Serbia 54% 37 32 43%/62%
Italy 54% 981 850 32%/73%
Brazil 54% 483 419 39%/68%
Haiti 53% 16 14 75%/39%
Yemen 53% 283 248 50%/56%
Japan 53% 106 94 57%/49%
Azerbaijan 53% 20 18 58%/47%
Lebanon 52% 12 11 60%/46%
Iraq 52% 169 155 60%/45%
Poland 52% 261 242 22%/76%
Angola 52% 28 26 65%/39%
Russia 52% 476 444 31%/69%
Algeria 52% 78 73 42%/60%
France 52% 358 336 35%/64%
Singapore 52% 17 16 59%/44%
New Zealand 51% 35 33 34%/64%
Sudan 51% 21 20 13%/73%
Mozambique 51% 44 42 72%/36%
Philippines 51% 24 23 79%/32%
Belgium 51% 87 84 43%/57%
Estonia 51% 32 31 91%/29%
Tunisia 51% 48 47 30%/69%
Iran 50% 221 217 43%/57%
Oman 50% 5 5 40%/60%
Chad 50% 9 9 100%/0%
Nigeria 50% 18 18 46%/52%
United Arab Emirates 50% 16 16 7%/88%
Mayotte 50% 2 2 100%/0%
Nicaragua 50% 6 6 0%/100%
Norway 50% 12 12 43%/60%
Israel 50% 36 36 39%/62%
Romania 50% 175 178 32%/64%
Congo 50% 58 59 39%/56%
Libyan Arab Jamahiriya 49% 29 30 47%/52%
Bulgaria 49% 28 29 52%/47%
Bosnia and Herzegovina 49% 63 66 30%/64%
Cuba 49% 18 19 36%/57%
Croatia 48% 74 80 18%/80%
Cote d'Ivoire 48% 35 38 56%/41%
Australia 48% 55 60 30%/67%
Czech 48% 140 153 32%/62%
Albania 48% 138 151 87%/13%
Kenya 48% 10 11 82%/10%
Chile 48% 68 75 65%/37%
Egypt 47% 89 99 51%/45%
Syrian Arab Republic 47% 60 67 41%/52%
Indonesia 47% 85 97 54%/39%
Afghanistan 47% 49 56 38%/55%
Venezuela 46% 33 38 52%/42%
Latvia 46% 6 7 83%/14%
Portugal 46% 108 127 24%/67%
Malta 45% 5 6 25%/57%
Malaysia 45% 5 6 100%/0%
Montenegro 45% 9 11 0%/100%
Cameroon 43% 36 47 37%/49%
Kuwait 43% 13 17 11%/100%
Timor-Leste 43% 3 4 0%/100%
Ireland 41% 25 36 47%/35%
Colombia 41% 34 49 35%/47%
Burkina Faso 41% 9 13 0%/82%
Guatemala 40% 4 6 0%/100%
Papua New Guinea 40% 4 6 100%/14%
Congo the 40% 4 6 17%/75%
Rwanda 38% 3 5 100%/0%
Mali 35% 11 20 56%/13%
Togo 33% 1 2 100%/0%
Gabon 33% 2 4 100%/0%
Madagascar 33% 1 2 100%/0%
Senegal 33% 4 8 33%/33%
Bolivia 30% 6 14 83%/7%
South Africa 26% 7 20 46%/7%
Guinea 20% 1 4 100%/0%
Mongolia 20% 1 4 0%/100%
Macao 20% 2 8 33%/14%
Ghana 0% 0 1 -/0%
Total 57% 18031 13473 55%/59%